Author: Dale HewettImportant: This article is for educational purposes and is not medical advice. Seizures are a serious neurological event. If you or someone you care for has a seizure disorder, your treatment plan should be directed by a board-certified neurologist or epileptologist. Never stop or substitute prescribed seizure medication without medical supervision.
The conversation about CBD and seizures is unusual in cannabinoid science: there is one specific, FDA-approved CBD-based prescription drug — Epidiolex — and there is everything else. Confusing the two has serious consequences. This page explains what Epidiolex actually is, what it is approved to treat, and why consumer CBD oils, gummies, and tinctures are not interchangeable with it.
The short version
- Epidiolex is an FDA-approved prescription drug containing pharmaceutical-grade cannabidiol. It is approved for seizures associated with three rare conditions: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex (TSC), in patients one year of age and older.
- Consumer CBD oils, gummies, capsules, and tinctures sold online and in retail are dietary supplements, not medications. They have not been approved by the FDA to treat seizures and should not be used as a substitute for prescribed antiepileptic drugs (AEDs) or Epidiolex.
- Outside of those three conditions, CBD has not been FDA-approved for any seizure indication. Research into CBD for other epilepsy types is ongoing but remains preliminary.
What Epidiolex actually is
Epidiolex was approved by the FDA in 2018, the first plant-derived cannabinoid medication approved in the United States. It is:
- A prescription-only oral solution
- Standardized to a specific concentration of pharmaceutical-grade CBD
- Dosed by weight (mg per kg) under neurologist supervision
- Approved through the FDA’s standard new-drug pathway, including randomized controlled trials in patients with the named conditions
Those clinical trials showed statistically significant reductions in seizure frequency for the specific patient populations studied. That is the basis for Epidiolex’s labeled use — and the reason brands cannot generalize from “Epidiolex reduces seizures” to “CBD reduces seizures.”
Why consumer CBD is not Epidiolex
Several differences matter clinically:
- Concentration and consistency. Epidiolex is manufactured to pharmaceutical standards with strict batch consistency. Consumer CBD products vary, and independent testing has repeatedly found that label claims do not always match contents.
- Approved dosing. Epidiolex dosing for the named conditions starts in the range of 5 mg/kg/day and can titrate higher under medical supervision. Most consumer CBD products are dosed for general wellness, an order of magnitude lower than the doses studied in the trials.
- Drug interactions. Epidiolex prescribers monitor for interactions with valproate (which can raise liver enzymes when combined with high-dose CBD), clobazam, and others. Self-administered consumer CBD bypasses that monitoring.
- Purity testing. Pharmaceutical CBD is tested for solvents, heavy metals, pesticides, and microbial contamination at every stage. Consumer products vary, which is why third-party testing is important when buying any supplement.
Research on CBD beyond the named conditions
Beyond Lennox-Gastaut, Dravet, and TSC, there is growing but still preliminary research on CBD and other epilepsy types. Some open-label studies and case series have looked at refractory epilepsy in pediatric patients. Findings have been mixed and the methodological quality varies.
What this means in practice:
- Researchers are continuing to study CBD in additional seizure contexts.
- Outside of the three FDA-approved indications, there is not yet sufficient evidence to support specific claims.
- Patients and families exploring CBD for other epilepsy types should do so only in consultation with a treating neurologist, ideally at an epilepsy center.
What the FDA has actually said about CBD seizure claims
The FDA has repeatedly warned and fined companies that have marketed consumer CBD products as treatments for seizures, epilepsy, or related conditions. The agency’s position is that:
- Consumer CBD products have not gone through the new-drug review process for any seizure indication.
- Marketing them as seizure treatments makes them unapproved new drugs.
- Patients deserve products whose efficacy and safety claims have been verified.
This is why authoritative health publications and reputable CBD brands describe the research carefully and never market consumer CBD as a seizure treatment.
Talking to your neurologist
If you are exploring whether CBD might fit into care, an honest conversation with your treating clinician is the right path. Useful questions:
- Is Epidiolex an appropriate option for my (or my child’s) condition? If not, why not?
- If I currently use a consumer CBD product, what should you know about it?
- Are there interactions with my current AEDs (valproate, clobazam, others) that I should be aware of?
- What blood work or monitoring do you recommend if I do continue using a CBD product?
What we offer at New Phase Blends
We make third-party-tested CBD products designed for general wellness use. They are not Epidiolex, are not a substitute for prescribed seizure medication, and are not formulated, tested, or marketed for the treatment of any seizure disorder. If you have a seizure condition, please continue to follow the plan your neurologist has built for you.
Frequently asked questions
Is CBD oil approved by the FDA for seizures? Only Epidiolex, a specific prescription cannabidiol medication, is FDA-approved — and only for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. Consumer CBD products are not.
Can I use a CBD gummy or oil instead of my seizure medication? No. Stopping or substituting prescribed antiepileptic medication without medical supervision is dangerous. Any change to a seizure-management plan should be made by a treating neurologist.
Why is Epidiolex different from the CBD oil sold online? Epidiolex is a pharmaceutical-grade prescription drug with standardized dosing, strict manufacturing, and FDA-approved trial evidence behind a specific use. Consumer CBD is a wellness supplement with none of those formal approvals.
Where can I learn more about how CBD interacts with the body? Our endocannabinoid system overview explains the underlying biology in plain language.
Disclaimer: The statements made on this page have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease, including epilepsy or any seizure disorder. The information here is for educational purposes only. Seizure conditions are serious; please follow the plan provided by your treating neurologist.
